Interesting to read that percutaneous coronary intervention did not confer any survival benefit (nor protection from myocardial infarction) in an international randomized controlled trial of 888 patients when compared to medical therapy!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
July 6, 2018
A detailed and somewhat disheartening analysis of stem cell therapy for cardiac failure.
In Global News: Different Opioid Quantities for Different Surgeries, Testing India’s Locally-Made Heart Valve, and VATS Versus Thoracotomy
June 29, 2018
Patient Care and General Interest
June 28, 2018
Chan and colleagues describe a stepwise approach to reducing the time to extubation after cardiac surgery, driven primarily by bedside providers as opposed to a conventional physician-directed approach.
May 25, 2018
Patient Care and General Interest Coal miners in central Appalachia in the US have an increasing incidence of severe black lung disease and an associated increased need for lung transplantation.
May 15, 2018
A sober editorial on a murine model of induced cardiac failure, which highlights the challenges of translating animal omics to humans
May 4, 2018
A detailed well-referenced update on cardiovascular biomarkers, included in a compendium issue of the periodical.
African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure
May 2, 2018
Using the Premier healthcare database, the authors analyzed the data of over 100,000 adult patients admitted to an ICU in the U.S.
Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease: 5-Year Clinical Outcomes of the Prospective Randomized Pilot Study
April 20, 2018
The authors present the 5-year follow-up results of the HYBRID trial, wherein 200 patients with multivessel disease requiring revascularization were randomized to either conventional coronary artery bypass grafting (CABG) or hybrid coronary revascularization (HCR). Notably, the patients undergoing HCR had a LIMA to LAD via a minimally invasive appr
MiniStern Trial: A Randomised Trial Comparing Ministernotomy to Full Median Sternotomy for Aortic Valve Replacement
March 19, 2018
A medium-size RCT comparing full sternotomy to limited sternotomy for conventional aortic valve replacement, presented at the SCTS Annual Meeting in Glasgow. The 7-10% one year attrition rate seems quite disappointing, and will most probably be discussed. We will await the full paper to see what was the learning curve for the innovative approach.